£5.0M
The funding will support the Edinburgh biotechnology firm in bringing its FDA-approved medical device to international markets.
Calcivis
Edinburgh biotechnology firm developing tools for the early detection and prevention of tooth decay.
£9.5MTotal raised
Edinburgh-based biotechnology firm developing medical devices and biologic agents for early detection of tooth decay.
Categories
Founders
AC
Adam Christie
CEO
Adam brings leadership experience from roles including chief executive at Calcivis and chief business officer at PowderMed. He holds non-executive and board positions at organisations such as Calcivis and the Scottish Association for Marine Science.
LinkedIn
Bruce Vernon
CTO
Bruce brings biotech and pharmaceuticals operating experience, having founded Calcivis and ProFactor Pharma alongside quality and site management roles at several organisations.
LinkedInInvestors
- £5.0M
- £4.5M
Funding history
£4.5M
The Edinburgh medical device firm secured backing from Archangels and the Scottish Investment Bank to prepare for its American market entry.